Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Prostate Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 66 articles: HTML format Text format

Single Articles

January 2012
1. SIMPSON MA , Weigel JA, Weigel PH
   Systemic blockade of the hyaluronan receptor for endocytosis (HARE) prevents lymph node metastasis of prostate cancer.
   Int J Cancer. 2012 Jan 10. doi: 10.1002/ijc.27427.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. BASSETT JK , Severi G, Baglietto L, Macinnis RJ, et al
   Weight change and prostate cancer incidence and mortality.
   Int J Cancer. 2011 Dec 31. doi: 10.1002/ijc.27414.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. NAIR-SHALLIKER V , Smith DP, Egger S, Hughes AM, et al
   Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: A case-control study.
   Int J Cancer. 2011 Dec 15. doi: 10.1002/ijc.27400.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
4. WRIGHT ME , Bowen P, Virtamo J, Albanes D, et al
   Estimated phytanic acid intake and prostate cancer risk: A prospective cohort study.
   Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27372.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LEE JB , Zhang K, Tam YY, Tam YK, et al
   Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer In Vivo.
   Int J Cancer. 2011 Nov 16. doi: 10.1002/ijc.27361.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ZHANG X , Song Y, Wu Y, Dong Y, et al
   Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.
   Int J Cancer. 2011;129:2502-11.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WU GH , Auvinen A, Maattanen L, Tammela TL, et al
   Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening.
   Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27340.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. GILBERT R , Metcalfe C, Fraser WD, Donovan J, et al
   Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
   Int J Cancer. 2011 Oct 27. doi: 10.1002/ijc.27327.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SHANMUGAM MK , Manu KA, Ong TH, Ramachandran L, et al
   Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.
   Int J Cancer. 2011;129:1552-63.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. ZHAO Z , Zeng G, Ma W, Ou L, et al
    Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen-independent progression in advanced prostate cancer.
    Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26459.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. VAN HEMELRIJCK M , Jungner I, Walldius G, Garmo H, et al
    Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation.
    Int J Cancer. 2011;129:1485-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. THOMPSON VC , Day TK, Bianco-Miotto T, Selth LA, et al
    A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.
    Int J Cancer. 2011 Sep 7. doi: 10.1002/ijc.26414.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
13. CIARLO M , Benelli R, Barbieri O, Minghelli S, et al
    Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/beta-catenin signaling in prostate cancer cells.
    Int J Cancer. 2011 Aug 30. doi: 10.1002/ijc.26402.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SELTH LA , Townley S, Gillis JL, Ochnik AM, et al
    Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
    Int J Cancer. 2011 Aug 30. doi: 10.1002/ijc.26405.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. WILSON KM , Giovannucci E, Stampfer MJ, Mucci LA, et al
    Dietary acrylamide and risk of prostate cancer.
    Int J Cancer. 2011 Aug 22. doi: 10.1002/ijc.26383.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. SIKAND K , Slaibi JE, Singh R, Slane SD, et al
    miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
    Int J Cancer. 2011;129:810-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. RICHMAN EL , Carroll PR, Chan JM
    Vegetable and fruit intake after diagnosis and risk of prostate cancer progression.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26348.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
18. TSUI KH , Chung LC, Feng TH, Chang PL, et al
    Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell prolifertation and cell invasion in prostate carcinoma cells.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26284.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. OKAMOTO R , Delansorne R, Wakimoto N, Doan NB, et al
    Inecalcitol, an analog of 1alpha,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells.
    Int J Cancer. 2011 Jul 5. doi: 10.1002/ijc.26279.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
20. OBINATA D , Takayama KI, Urano T, Murata T, et al
    ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration.
    Int J Cancer. 2011 Jun 6. doi: 10.1002/ijc.26224.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
21. OTTINGER S , Kloppel A, Rausch V, Liu L, et al
    Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26168.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
22. SINHA I , Null K, Wolter W, Suckow MA, et al
    Methylseleninic acid down regulates hypoxia inducible factor-1alpha in invasive prostate cancer.
    Int J Cancer. 2011 Apr 15. doi: 10.1002/ijc.26141.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. WOLFF DW , Xie Y, Deng C, Gatalica Z, et al
    Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.
    Int J Cancer. 2011 Apr 15. doi: 10.1002/ijc.26138.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. VICKERS AJ , Savage CJ, Bianco FJ, Klein EA, et al
    Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.
    Int J Cancer. 2011;128:1697-702.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
25. OPSTRUP ABILDGAARD M , Borre M, Morck Mortensen M, Ulhoi BP, et al
    Downregulation of ZNF132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26097.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. BAO BY , Pao JB, Huang CN, Pu YS, et al
    Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26091.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. KAWADA J , Wada H, Isobe M, Gnjatic S, et al
    Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
    Int J Cancer. 2011 Mar 16. doi: 10.1002/ijc.26074.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SZARVAS T , Becker M, Vom Dorp F, Meschede J, et al
    Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
    Int J Cancer. 2011;128:1486-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. WACH S , Nolte E, Szczyrba J, Stohr R, et al
    MiRNA profiles of prostate carcinoma detected by multi-platform miRNA screening.
    Int J Cancer. 2011 Mar 11. doi: 10.1002/ijc.26064.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. JIANG Q , Rao X, Young Kim C, Freiser H, et al
    Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide.
    Int J Cancer. 2011 Mar 11. doi: 10.1002/ijc.26054.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. OBINATA D , Takayama KI, Urano T, Murata T, et al
    Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26043.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. ROBINSON D , Garmo H, Lindahl B, Van Hemelrijck M, et al
    Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26022.
    PubMed     Text format     Related articles   
    
    
    
    
33. RODEBERG DA , Anderson JR, Arndt CA, Ferrer FA, et al
    Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society
    Int J Cancer. 2011;128:1232-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. JIN JK , Dayyani F, Gallick GE
    Steps in prostate cancer progression that lead to bone metastasis.
    Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26024.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
35. HASEGAWA M , Miyajima A, Kosaka T, Yasumizu Y, et al
    Low dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SZMULEWITZ RZ , Clark R, Lotan T, Otto K, et al
    "MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression"
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26005.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. HENSLEY HH , Hannoun-Levi JM, Hachem P, Mu Z, et al
    PKA knockdown enhances cell killing in response to radiation and androgen deprivation.
    Int J Cancer. 2011;128:962-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ZHANG Y , Kim KH, Zhang W, Guo Y, et al
    Galbanic acid decreases androgen receptor abundance and signaling and induces G(1) arrest in prostate cancer cells.
    Int J Cancer. 2011 Feb 15. doi: 10.1002/ijc.25993.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. JOHANSSON M , Holmstrom B, Hinchliffe SR, Bergh A, et al
    Combining 33 genetic variants with prostate specific antigen for prediction of prostate cancer: Longitudinal study.
    Int J Cancer. 2011 Feb 15. doi: 10.1002/ijc.25986.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. ZHONG WD , Liang YX, Lin SX, Li L, et al
    Expression of CD147 is associated with prostate cancer progression.
    Int J Cancer. 2011 Feb 15. doi: 10.1002/ijc.25982.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. BERNATSKY S , Ramsey-Goldman R, Gordon C, Clarke AE, et al
    Prostate cancer in systemic lupus erythematosus.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25956.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. TENG Y , Liu M, Cowell JK
    Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25964.
    PubMed     Text format     Related articles   
    
    
    
    
43. ATCHISON EA , Gridley G, Carreon JD, Leitzmann MF, et al
    Risk of cancer in a large cohort of U.S. veterans with diabetes.
    Int J Cancer. 2011;128:635-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. FRIEDMAN GD , Udaltsova N, Habel LA
    Norepinephrine antagonists and cancer risk.
    Int J Cancer. 2011;128:737-8.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
45. ZHU X , van Leeuwen PJ, Bul M, Bangma CH, et al
    Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam).
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25947.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. THAMILSELVAN V , Menon M, Thamilselvan S
    Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 beta/beta-catenin pathway.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25949.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. BACHMANN HS , Heukamp LC, Schmitz KJ, Hilburn CF, et al
    Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. CROPP CD , Simpson CL, Wahlfors T, Ha N, et al
    Genome-wide linkage scan for prostate cancer susceptibility in finland: Evidence for a novel locus on 2q37.2 and confirmation of signal on 17q21-q22.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. LIU L , Kron KJ, Pethe VV, Demetrashvili N, et al
    Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3, and RASSF1A with prostate cancer progression.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
50. HATANO K , Miyamoto Y, Nonomura N, Kaneda Y, et al
    Expression of gangliosides, GD1a and sialyl paragloboside, is regulated by NF-kappaB-dependent transcriptional control of alpha2,3-sialyltransferase I, II and VI in human castration-resistant prostate cancer cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. HAGMAN Z , Larne O, Edsjo A, Bjartell A, et al
    miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Int J Cancer. 2010;127:2768-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. JONSSON H , Holmstrom B, Duffy SW, Stattin P, et al
    Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. THOMASSON M , Wang B, Hammarsten P, Dahlman A, et al
    LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. DHILLON PK , Kenfield SA, Stampfer MJ, Giovannucci EL, et al
    Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KATANASAKA Y , Ishii T, Asai T, Naitou H, et al
    Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78.
    Int J Cancer. 2010;127:2685-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
56. RABIEN A , Fritzsche FR, Jung M, Tolle A, et al
    KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
    Int J Cancer. 2010;127:2386-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. VAN HEMELRIJCK M , Jungner I, Walldius G, Garmo H, et al
    Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. SIKAND K , Slaibi JE, Singh R, Slane SD, et al
    miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. NURMINEN R , Wahlfors T, Tammela TL, Schleutker J, et al
    Identification of an aggressive prostate cancer predisposing variant at 11q13.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. CHAMBERLAIN C , Romundstad P, Vatten L, Gunnell D, et al
    The association of weight gain during adulthood with prostate cancer incidence and survival: A population based cohort.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
61. HONG Y , Macnab S, Lambert LA, Turner AJ, et al
    Herpesvirus saimiri (HVS)-based endothelin converting enzyme-1 (ECE-1) shRNA expression decreases prostate cancer cell invasion and migration.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
62. FUJITA K , Ewing CM, Isaacs WB, Pavlovich CP, et al
    Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. GONG Y , Li Y, Lu Y, Li L, et al
    Bioactive tanshinones in Salvia Miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
64. HUANG C , Liu S, Miller RT
    Role of p115RhoGEF in the regulation of extracellular Ca(2+)-induced choline kinase activation and prostate cancer cell proliferation.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. COLONNA M , Bossard N, Remontet L, Grosclaude P, et al
    Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancers.
    Int J Cancer. 2010;127:924-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
66. FRANK O'BRIEN M , Cronin AM, Fearn PA, Savage CJ, et al
    Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: